Sat.Jan 18, 2025 - Fri.Jan 24, 2025

article thumbnail

Driving Biopharma Innovation and Operational Excellence in 2025

Pharma IQ

Discover how advancements in unified systems, patient diversity, and regulatory submissions will accelerate drug development & improve patient outcomes.

Biopharma 130
article thumbnail

Innovative Health Initiative launches a trial aimed at ending Crohn’s Disease

PharmaTimes

Europes first biomarker trial seeks to prevent Crohns Disease onset

138
138
article thumbnail

NVIDIA champions Innophore partnership to model drug dynamics with AI

Pharmaceutical Technology

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

article thumbnail

Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More

MedCity News

Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said. The post Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More appeared first on MedCity News.

Pharma 109
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

UK kicks off £150m tender process for healthcare AI

pharmaphorum

The UK government has launched a 150 million procurement drive for artificial intelligence tools that can be used by the NHS.

article thumbnail

AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025

PharmaTimes

Preclinical data highlights potential in treating Alzheimer's disease

112
112

More Trending

article thumbnail

Changing the Prostate Cancer Screening Landscape

MedCity News

Large numbers of men could have missed a prostate cancer diagnosis due to Covid-19. Combine that with a rise in prostate cancer and the future looks grim. Ultimately, something in the prostate cancer diagnostic landscape needs to change: but what? The post Changing the Prostate Cancer Screening Landscape appeared first on MedCity News.

article thumbnail

Sun Pharma unit poised to buy Canadian biotech Antibe

pharmaphorum

Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation

Pharma 111
article thumbnail

UK sees 70% increase in phase I advanced therapy clinical trials in 2024

PharmaTimes

Cell and Gene Therapy Catapult reveals significant growth in UK trials

111
111
article thumbnail

Purdue and Sackler family agree to $7.4bn national opioid settlement

Pharmaceutical Technology

The settlement ends the Sackler familys ownership of the Oxycontin developer Purdue Pharma.

Pharma 111
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Allara Health Secures $26M to Advance Women’s Hormonal Care

MedCity News

Allara Health’s $26 million Series B raise was led by Index Ventures and included participation from Google Ventures. In total, the company has raised $38.5 million. The post Allara Health Secures $26M to Advance Womens Hormonal Care appeared first on MedCity News.

113
113
article thumbnail

UnitedHealth names CEO to replace slain Thompson

pharmaphorum

UnitedHealth has appointed company veteran Tim Noel as CEO of its UnitedHealthcare insurance unit, after the murder last month of Brian Thompson.

Insurance 106
article thumbnail

AstraZeneca receives positive recommendations for lung cancer treatments

PharmaTimes

NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care

108
108
article thumbnail

FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases

Pharmaceutical Technology

The FDA reported that six patients died after being injected with Tevas Copaxone or Sandozs Glatopa.

FDA 105
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Zero-Sum Game: The Current Healthcare System Is Reaching a Breaking Point

MedCity News

Its tragic that it takes a shooter, aggravated by his back pain and frustrated with the healthcare system, to spark a necessary conversation about healthcare. The post Zero-Sum Game: The Current Healthcare System Is Reaching a Breaking Point appeared first on MedCity News.

article thumbnail

Purdue and Sacklers agree new $7.4bn opioid settlement

pharmaphorum

Purdue Pharma and the Sackler family who own the company have proposed a new $7.

Pharma 104
article thumbnail

Tris Pharma announces positive results from ALLEVIATE-1 trial of cebranopadol

PharmaTimes

Phase 3 trial shows promising pain relief for acute pain patients

Pharma 105
article thumbnail

Stealth faces another hurdle as FDA delays decision on Barth syndrome drug

Pharmaceutical Technology

The FDA rejected the companys initial NDA in 2021, citing the lack of an adequate trial to demonstrate efficacy.

FDA 102
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Battling Ransomware: How Healthcare Organizations Can Strengthen Cybersecurity to Protect Patient Data

MedCity News

Recognizing its vulnerability to cybercrime, the healthcare industry continues to prioritize cybersecurity. Here are some areas where organizations should be focusing their efforts. The post Battling Ransomware: How Healthcare Organizations Can Strengthen Cybersecurity to Protect Patient Data appeared first on MedCity News.

article thumbnail

Could OTC Cialis for erectile dysfunction reach the US?

pharmaphorum

Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market

article thumbnail

Datapharm expands into US market through partnership with phactMI

PharmaTimes

Collaboration aims to enhance accessibility of medicines information

Marketing 100
article thumbnail

$590m to Moderna from HHS for mRNA ‘flu vax development

Pharmaceutical Technology

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines.

103
103
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Centivo Launches Virtual Primary Care Offering for Employers

MedCity News

Through Centivo Care, patients can access free appointments, a dedicated primary care team and behavioral health support. The post Centivo Launches Virtual Primary Care Offering for Employers appeared first on MedCity News.

Patients 107
article thumbnail

AMR biotech BioVersys plans to float on Swiss stock exchange

pharmaphorum

BioVersys has filed to list on the Swiss Stock Exchange, hoping to raise CHF80m for its novel antibacterial candidates.

104
104
article thumbnail

Beyond copays: Redefining assistance for those with rare diseases and chronic conditions

PharmaVoice

Accessia Health helps ease the burden of managing a rare disease or chronic condition.

article thumbnail

EC approves lazertinib in combination with amivantamab for NSCLC patients

PharmaTimes

Combination therapy shows superior survival benefit over standard treatment

article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

Why Sentara Health Invested $11M Into iPhones for Nurses 

MedCity News

Sentara Health invested $11 million into smartphones for its nurses, equipping them with HIPAA-compliant devices to streamline communication, increase time at the bedside and improve patient outcomes. The program has been going on for a little more than a year and Amy Rosa, the health systems chief nursing informatics officer, says the initiative is already resulting in increased efficiency, documentation accuracy and patient safety.

Safety 113
article thumbnail

High-dose semaglutide ramps up weight loss, says Novo

pharmaphorum

Novo Nordisk's high-dose version of semaglutide boosts its weight-loss ability, but it still can't match its main rival in the obesity market

Marketing 105
article thumbnail

Artificial Intelligence and Life Expectancy: How AI Will Contribute to Improving Human Health.

MaBiCo

Artificial Intelligence and Life Expectancy: How AI Will Contribute to Improving Human Health. This article was written by Evangelos Mantzafos, Business Development Manager of MaBiCo. Ever since artificial intelligence applications entered our lives and increasingly more people started using them, we all feel that something big is coming (or rather has already come) that will change the way we work, communicate, and generally change our daily lives to an extent and speed that has never happened

article thumbnail

Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment

PharmaTimes

Orphan drug designation offers development incentives and potential market exclusivity

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten